@article{filleron_t_statistical_2016,
title = {Statistical controversies in clinical research: should schedules of tumor size assessments be changed?},
volume = {27},
issn = {0923-7534},
url = {http://www.ncbi.nlm.nih.gov/pubmed/27502711},
DOI = {10.1093/annonc/mdw292},
Language = {English},
Journal = {Ann. Oncol.},
author = {{Filleron T} and {Kouokam W} and {Gilhodes J} and {Duhamel A} and {Penel N} and {Joly F} and {Tresch-Bruneel E} and {Kramar A} and {Houédé N}},
year = {2016},
keywords = {Antineoplastic Agents/therapeutic use, Biomedical Research/statistics & numerical data*, Clinical Trials, Phase II as Topic/statistics & numerical data*, Disease Progression, Humans, Neoplasms/drug therapy*, Tumor Burden/drug effects},
pages = {1981-1987}
}

{"_id":"xC5iCrjNs8K6cTag4","bibbaseid":"filleront-kouokamw-gilhodesj-duhamela-peneln-jolyf-treschbruneele-kramara-etal-statisticalcontroversiesinclinicalresearchshouldschedulesoftumorsizeassessmentsbechanged-2016","authorIDs":[],"author_short":["Filleron T","Kouokam W","Gilhodes J","Duhamel A","Penel N","Joly F","Tresch-Bruneel E","Kramar A","Houédé N"],"bibdata":{"bibtype":"article","type":"article","title":"Statistical controversies in clinical research: should schedules of tumor size assessments be changed?","volume":"27","issn":"0923-7534","url":"http://www.ncbi.nlm.nih.gov/pubmed/27502711","doi":"10.1093/annonc/mdw292","language":"English","journal":"Ann. Oncol.","author":[{"firstnames":[],"propositions":[],"lastnames":["Filleron T"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Kouokam W"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Gilhodes J"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Duhamel A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Penel N"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Joly F"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Tresch-Bruneel E"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Kramar A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Houédé N"],"suffixes":[]}],"year":"2016","keywords":"Antineoplastic Agents/therapeutic use, Biomedical Research/statistics & numerical data*, Clinical Trials, Phase II as Topic/statistics & numerical data*, Disease Progression, Humans, Neoplasms/drug therapy*, Tumor Burden/drug effects","pages":"1981-1987","bibtex":"@article{filleron_t_statistical_2016,\r\ntitle = {Statistical controversies in clinical research: should schedules of tumor size assessments be changed?},\r\nvolume = {27},\r\nissn = {0923-7534},\r\nurl = {http://www.ncbi.nlm.nih.gov/pubmed/27502711},\r\nDOI = {10.1093/annonc/mdw292},\r\nLanguage = {English},\r\nJournal = {Ann. Oncol.},\r\nauthor = {{Filleron T} and {Kouokam W} and {Gilhodes J} and {Duhamel A} and {Penel N} and {Joly F} and {Tresch-Bruneel E} and {Kramar A} and {Houédé N}},\r\nyear = {2016},\r\nkeywords = {Antineoplastic Agents/therapeutic use, Biomedical Research/statistics & numerical data*, Clinical Trials, Phase II as Topic/statistics & numerical data*, Disease Progression, Humans, Neoplasms/drug therapy*, Tumor Burden/drug effects},\r\npages = {1981-1987}\r\n}\r\n\r\n","author_short":["Filleron T","Kouokam W","Gilhodes J","Duhamel A","Penel N","Joly F","Tresch-Bruneel E","Kramar A","Houédé N"],"key":"filleron_t_statistical_2016","id":"filleron_t_statistical_2016","bibbaseid":"filleront-kouokamw-gilhodesj-duhamela-peneln-jolyf-treschbruneele-kramara-etal-statisticalcontroversiesinclinicalresearchshouldschedulesoftumorsizeassessmentsbechanged-2016","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/27502711"},"keyword":["Antineoplastic Agents/therapeutic use","Biomedical Research/statistics & numerical data*","Clinical Trials","Phase II as Topic/statistics & numerical data*","Disease Progression","Humans","Neoplasms/drug therapy*","Tumor Burden/drug effects"],"downloads":0},"bibtype":"article","biburl":"https://pro.univ-lille.fr/fileadmin/user_upload/pages_pros/patrick_devos/duhamel.bib","creationDate":"2019-06-21T09:30:54.922Z","downloads":0,"keywords":["antineoplastic agents/therapeutic use","biomedical research/statistics & numerical data*","clinical trials","phase ii as topic/statistics & numerical data*","disease progression","humans","neoplasms/drug therapy*","tumor burden/drug effects"],"search_terms":["statistical","controversies","clinical","research","schedules","tumor","size","assessments","changed","filleron t","kouokam w","gilhodes j","duhamel a","penel n","joly f","tresch-bruneel e","kramar a","houédé n"],"title":"Statistical controversies in clinical research: should schedules of tumor size assessments be changed?","year":2016,"dataSources":["Tt6zYqvN5kE3wbwiR"]}